GSK Plus Sanofi: The COVID-19 Vaccine Dream Team?

Tried-And-Tested Platforms Could Pay Off

 
• By Andrew McConaghie
  
GSK_HQ
By pooling its expertise and manufacturing scale with rivals Sanofi on the COVID-19 vaccine, GSK is increasing the odds of success
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip